Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overexpression of inflammatory human caspase-4 in relation to clinical severity of oral lichen planus. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2025 | 39979138 | PubTator, text mining | PubMed |
| Insights on the crosstalk among different cell death mechanisms. | Cell Death Discov | 2025 | 39929794 | PubTator, text mining | PubMed |
| Machine Learning and Experiments Revealed Key Genes Related to PANoptosis Linked to Drug Prediction and Immune Landscape in Spinal Cord Injury. | Mol Neurobiol | 2025 | 39888480 | PubTator, text mining | PubMed |
| Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer. | Gastro Hep Adv | 2025 | 39866724 | PubTator, text mining | PubMed |
| CASP5 associated with PANoptosis promotes tumorigenesis and progression of clear cell renal cell carcinoma. | Cancer Cell Int | 2025 | 39780201 | PubTator, text mining | PubMed |
| A rich component of Fructus Aurantii, meranzin hydrate, exerts antidepressant effects via suppressing caspase4 to regulate glial cell and neuronal functions in the hippocampus. | Biomed Pharmacother | 2025 | 39675136 | PubTator, text mining | PubMed |
| A complex of NLRP3 with caspase-4 is essential for inflammasome activation by Tannerella forsythia infection. | Int Immunol | 2025 | 39673522 | PubTator, text mining | PubMed |
| Immunomodulatory effect of lithium treatment on in vitro model of neuroinflammation. | Neuropharmacology | 2025 | 39586495 | PubTator, text mining | PubMed |
| Convergent effects of synthetic glucocorticoid dexamethasone and amyloid beta in human olfactory neurosphere-derived cells. | J Neurochem | 2025 | 39556451 | PubTator, text mining | PubMed |
| Functional interplay between non-canonical inflammasomes and autophagy in inflammatory responses and diseases. | Korean J Physiol Pharmacol | 2025 | 39539180 | PubTator, text mining | PubMed |
| Regulatory Roles of Noncanonical Inflammasomes in Inflammatory Lung Diseases. | Int J Mol Sci | 2024 | 39795884 | PubTator, text mining | PubMed |
| Pyroptosis in Endothelial Cells and Extracellular Vesicle Release in Atherosclerosis via NF-κB-Caspase-4/5-GSDM-D Pathway. | Pharmaceuticals (Basel) | 2024 | 39770410 | PubTator, text mining | PubMed |
| Estimation of noncanonical pyroptosis biomarkers gasdermin D and caspase 4 in gingiva of periodontitis and diabetes patients: An observational cross-sectional study. | J Indian Soc Periodontol | 2024 | 39742067 | PubTator, text mining | PubMed |
| Kaempferol alleviates rheumatoid arthritis through pyroptosis based on bioinformatics analysis and experimental validation. | Sci Rep | 2024 | 39616227 | PubTator, text mining | PubMed |
| Newcastle disease virus promotes pyroptosis in medulloblastoma cells by regulating interferon-gamma-mediated guanylate-binding protein 1 expression and activating caspase-4. | Cytojournal | 2024 | 39563668 | PubTator, text mining | PubMed |
| Seed sequences mediate off-target activity in the CRISPR-interference system. | Cell Genom | 2024 | 39510079 | PubTator, text mining | PubMed |
| Evolutionary Dynamics of Proinflammatory Caspases in Primates and Rodents. | Mol Biol Evol | 2024 | 39431598 | PubTator, text mining | PubMed |
| CRISPR-GEM: A Novel Machine Learning Model for CRISPR Genetic Target Discovery and Evaluation. | ACS Synth Biol | 2024 | 39375864 | PubTator, text mining | PubMed |
| The ER Stress Induced in Human Neuroblastoma Cells Can Be Reverted by Lumacaftor, a CFTR Corrector. | Curr Issues Mol Biol | 2024 | 39329905 | PubTator, text mining | PubMed |
| Pathogenic diversification of the gut commensal Providencia alcalifaciens via acquisition of a second type III secretion system. | Infect Immun | 2024 | 39254346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=6